Sponsors

Olink Proteomics available in the UK via Source Genomics

Source Genomics is the first UK-based commercial service provider of Olink Proteomics. The company has partnered with Olink to maximise the power of proteomics, providing high-throughput and scalable biomarker discovery for laboratory projects with unparalleled specificity.

Olink uses innovative Proximity Extension Assay (PEA) technology to measure large numbers of proteins, supporting high-quality biomarker discovery. By combining the PEA protein technology with NGS, Olink allows researchers to conduct high-throughput proteomics without compromising specificity and sensitivity of the assay. This breakthrough in genomic analysis technologies requires minimal sample, less than a drop of blood, while maintaining specificity and sensitivity at the highest level.

Olink Explore panels are categorised into four disease areas: cardiometabolic, inflammation, neurology and oncology, elevating the potential for biomarker discovery in a wide range of health and disease landscapes:

  • Identification of novel drug targets
  • Disease prediction and patient stratisfication
  • In-vivo/in-vitro testing in preclinical research
  • Aid understanding of real-time human biology.

Olink provides free consultation at initiation and projects are assigned to an experienced scientist as Project Manager to provide support and updates throughout the project and post data delivery.

Learn more at https://sourcebioscience.com/genomics/olink/.

 

Latest Issues

DIA-MHRA Global Summit

Senate House, Malet Street, London, WC1E 7HU
16-17 November, 2026

UK NEQAS for Microbiology & Parasitology Annual Scientific Meeting 2026

The Royal National Hotel, 38 – 51 Bedford Way, London, WC1H 0DG
27 November, 2026

UK NEQAS webinar: Epigenetics

Online
1 December, 2026

Weqas Annual POCT Conference 2026

London, Venue - TBC
8-9 December, 2026

UK NEQAS webinar: Fresh Muscle Biopsies

Online
8 December, 2026